DEXERIALS CORPORATION's next confirmed earnings release is scheduled for November 11, 2026.
| Earnings Date | 11/11/2026 |
As of March 31, 2026, DEXERIALS CORPORATION has 167.51M shares outstanding.
| Shares Outstanding | 167.51M |
As of March 31, 2026, DEXERIALS CORPORATION maintains a current ratio of 1.31, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.31 |
| Quick Ratio | 0.44 |
| Debt / Equity | 15.09 |
These figures cover the twelve months ended March 31, 2026.
| Employee Count | 1,866.50 |
As of the close on August 4, 2026, DEXERIALS CORPORATION's stock has gained approximately 61.22% over the past 52 weeks.
| 52-Week Price Change | 61.22% |
As of March 31, 2026, DEXERIALS CORPORATION holds 105.06M in cash and equivalents against 104.02M in total debt, resulting in a net debt position of -938,973.05. Total book value stands at 689.19M, with working capital of 73.57M providing operational flexibility.
| Cash & Cash Equivalents | 105.06M |
| Total Debt | 104.02M |
| Net Debt | -938,973.05 |
| Equity (Book Value) | 689.19M |
| Book Value Per Share | 4.11 |
| Working Capital | 73.57M |
DEXERIALS CORPORATION's most recent stock split took place on September 27, 2024 with a 1:3 split ratio.
| Last Split Date | 9/27/2024 |
| Split Ratio | 1:3 |
Already premium?